AI	Artificial intelligence
ALK	Anaplastic lymphoma kinase
APC	Antigen-presenting cell
BCG	Bacillus Calmette-Guerin
BiTE	Bispecific T-cell engager
CBI	Checkpoint blockade immunotherapy
CEA	Carcinoembryonic antigen
CTA	Cancer/testis antigen
CTL	Cytotoxic T-lymphocyte
DC	Dendritic cell
EGF	Epidermal growth factor
EGFR	Epidermal growth factor receptor
ESCs	Embryonic stem cells
EML-4	Echinoderm microtubule-associated protein-like 4
FDA	Food and Drug Administration
GM-CSF	Granulocyte-macrophage colony-stimulating factor
ICIs	Immune checkpoint inhibitors
IL-12	Interleukin 12
IL-23	Interleukin 23
iPSC	Irradiated pluripotent stem cells
KLH	Keyhole limpet hemocyanin
MAGE-A3	Melanoma antigen family A, 3
MHC I	Major histocompatibility complex I
MHC II	Major histocompatibility complex
MOS	Median overall survival
MUC 1	Mucin 1
NK	Natural killer
NSCLC	Non-small cell lung cancer
NY-ESO-1	New York esophageal squamous cell carcinoma
OS	Overall survival
PFS	Progression-free survival
PR	Partial response
PSA	Prostate-specific antigen
RECIST	Response Evaluation Criteria in Solid Tumors
SCLC	Small cell lung cancer
SD	Stable disease
TAAs	Tumor-associated antigens
TACA	Tumor-associated carbohydrate antigens
TCR	T-cell receptor
TKIs	Tyrosine kinase inhibitors
TME	Tumor microenvironment
TNF-α	Tumor necrosis factor alpha